Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Emergence Delirium × Sufentanil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 3 Pain 3 Carcinoma, Hepatocellular 3 Pain, Postoperative 2 Lung Neoplasms 2 Inflammation 2 Stomach Neoplasms 1 Postoperative Nausea and Vomiting 1 Pancreatic Neoplasms 1 Neuroma, Acoustic 1 Melanoma 1 Gynecological Laparoscopic Surgery 1 Emergence Delirium 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms 1

Interventions

Saline Solution 3 Propofol 3 Dexmedetomidine 3 remimazolam 2 Sugammadex 1 Sufentanil 1 Spectroscopy, Near-Infrared 1 Sodium Chloride 1 Ropivacaine 1 Pyridostigmine Bromide 1 Neuroleptanalgesia 1 Nalbuphine 1 Minocycline 1 Midazolam 1 Methylene Blue 1 Ketamine 1 Injections 1 Ibuprofen 1 Duloxetine Hydrochloride 1 Blood Specimen Collection 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05596071 2022-10-27

POD

Zhejiang Cancer Hospital

Phase NA Completed

Gastrointestinal

Emergence Delirium, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡